<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>12(20)</volume><submitter>Zhang H</submitter><pubmed_abstract>Targeting autophagy holds promise to enhance chemosensitivity in acute myeloid leukemia (AML). MicroRNA-143 (miR-143) has been found to suppress autophagy, however, it is not clear whether miR-143 augments cytarabine cytotoxicity in AML. Here, we report that cytarabine treatment reduces miR-143 expression in AML cell lines and primary AML cells. Moreover, ectopic expression of miR-143 further decreases cell viability in cytarabine-treated AML cells. By contrast, miR-143 knockdown inhibits cytarabine-induced cytotoxicity, together indicating a role of miR-143 in enhancing cytarabine sensitivity in AML. Subsequently, we show that miR-143 inhibits autophagy in cytarabine-treated AML cells by directly targeting autophagy-related proteins (ATG), ATG7 and ATG2B, two critical known components of </pubmed_abstract><journal>Aging</journal><pagination>20111-20126</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7655171</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>MicroRNA-143 sensitizes acute myeloid leukemia cells to cytarabine via targeting ATG7- and ATG2B-dependent autophagy.</pubmed_title><pmcid>PMC7655171</pmcid><pubmed_authors>Liu L</pubmed_authors><pubmed_authors>Tao Y</pubmed_authors><pubmed_authors>Zhang H</pubmed_authors><pubmed_authors>Chen L</pubmed_authors><pubmed_authors>Kang J</pubmed_authors><pubmed_authors>Ren S</pubmed_authors></additional><is_claimable>false</is_claimable><name>MicroRNA-143 sensitizes acute myeloid leukemia cells to cytarabine via targeting ATG7- and ATG2B-dependent autophagy.</name><description>Targeting autophagy holds promise to enhance chemosensitivity in acute myeloid leukemia (AML). MicroRNA-143 (miR-143) has been found to suppress autophagy, however, it is not clear whether miR-143 augments cytarabine cytotoxicity in AML. Here, we report that cytarabine treatment reduces miR-143 expression in AML cell lines and primary AML cells. Moreover, ectopic expression of miR-143 further decreases cell viability in cytarabine-treated AML cells. By contrast, miR-143 knockdown inhibits cytarabine-induced cytotoxicity, together indicating a role of miR-143 in enhancing cytarabine sensitivity in AML. Subsequently, we show that miR-143 inhibits autophagy in cytarabine-treated AML cells by directly targeting autophagy-related proteins (ATG), ATG7 and ATG2B, two critical known components of </description><dates><release>2020-01-01T00:00:00Z</release><publication>2020 Oct</publication><modification>2025-05-18T12:43:50.56Z</modification><creation>2025-04-06T17:52:34.4Z</creation></dates><accession>S-EPMC7655171</accession><cross_references><pubmed>33077697</pubmed><doi>10.18632/aging.103614</doi></cross_references></HashMap>